DHA / DOH / MOH exam (UAE) neurology questions

This patient presents within the 4.5-hour window with a disabling deficit, no hemorrhage on CT, and blood pressure controlled below 185/110 mmHg, meeting criteria for intravenous thrombolysis. Routine coagulation studies need not delay treatment unless the patient is on warfarin, has a bleeding disorder, or recent coagulopathy is suspected. Door-to-needle time should be minimized, so waiting for an MRI or unnecessary labs is inappropriate. Antiplatelets are deferred until 24 hours after thrombolysis to avoid increasing hemorrhage risk.

• A. MRI is not required for standard eligibility assessment and would delay time-critical treatment.
• C. Alteplase should not be delayed for routine coagulation results unless anticoagulant use or bleeding diathesis is suspected.
• D. Aspirin alone is inferior to thrombolysis in a patient who qualifies for alteplase within the window.

Non-contrast CT of the brain is the fastest and most widely available initial test in suspected acute stroke and is essential to exclude intracranial hemorrhage before any reperfusion therapy is considered. It can be completed within minutes and does not require the patient to be stable for a longer scan. MRI, carotid duplex, and echocardiography provide useful information later but should never delay the initial CT and subsequent treatment decision.

• B. MRI takes longer to perform and is not required before the decision to thrombolyse; it should not delay initial management.
• C. Echocardiography is used later to evaluate for a cardioembolic source, not in the hyperacute phase.
• D. Carotid duplex helps identify the stroke etiology but has no role in the hyperacute treatment decision.

This patient has a confirmed large vessel occlusion with a favorable core-to-penumbra mismatch on perfusion imaging, which extends the window for mechanical thrombectomy up to 24 hours from last known well in selected patients. Mechanical thrombectomy restores perfusion directly and improves functional outcomes in this population. Intravenous alteplase alone is not recommended beyond the 4.5-hour window, and anticoagulation or antiplatelet therapy alone will not achieve timely recanalization of a large vessel occlusion.

• B. Intravenous alteplase is not indicated beyond 4.5 hours from onset and would not address the large vessel occlusion.
• C. Antiplatelet therapy does not recanalize a major vessel occlusion and risks losing salvageable tissue.
• D. Acute anticoagulation is not standard therapy for acute ischemic stroke and increases hemorrhage risk.

Acute blood on non-contrast CT appears hyperdense (bright) relative to brain parenchyma because of its high protein and hemoglobin content, whereas acute ischemic infarction typically appears hypodense or may show no visible change for the first few hours. The basal ganglia location and surrounding edema with mass effect are typical for a hypertensive intracerebral hemorrhage. Recognizing this hyperdensity is critical because it excludes the patient from thrombolytic therapy and changes management to blood pressure control and neurosurgical evaluation.

• A. A chronic lacunar infarct would appear as an old, well-defined hypodense cavity without acute mass effect.
• B. Atrophy presents as diffuse volume loss, not a focal hyperdense lesion with mass effect.
• D. Acute ischemic infarction appears hypodense, not hyperdense, on non-contrast CT in the early hours.

Pure motor hemiparesis affecting the face, arm, and leg equally without cortical signs such as aphasia, neglect, or visual field loss is the classic presentation of a lacunar infarct involving the posterior limb of the internal capsule or the corona radiata. These small vessel infarcts result from occlusion of a single penetrating artery, commonly due to chronic hypertension and diabetes. A cortical (middle cerebral artery) infarct would typically produce cortical signs such as aphasia or neglect, which are absent here.

• A. A middle cerebral artery cortical infarct typically also causes cortical signs such as aphasia, neglect, or homonymous hemianopia, which are absent in this patient.
• B. Subarachnoid hemorrhage typically presents with sudden severe headache and meningism, not isolated motor weakness.
• C. Posterior cerebral artery infarcts classically cause visual field defects, not isolated pure motor weakness.

For long-term secondary prevention after a non-cardioembolic ischemic stroke, guidelines recommend long-term single antiplatelet therapy, with clopidogrel 75 mg daily being a preferred first-line option due to its efficacy and favorable side-effect profile compared with aspirin alone. Anticoagulants such as warfarin or dabigatran are reserved for cardioembolic strokes, such as those due to atrial fibrillation, which has been excluded in this patient. Heparin infusion has no role in long-term secondary stroke prevention.

• A. Heparin infusion is not used for long-term secondary stroke prevention and carries bleeding risk without proven benefit here.
• C. Warfarin is indicated for cardioembolic stroke, such as atrial fibrillation, which has been excluded in this patient.
• D. Dabigatran is a direct oral anticoagulant indicated for cardioembolic stroke prevention, not for non-cardioembolic atherosclerotic stroke.

A thunderclap headache reaching peak intensity within seconds to minutes is the classic presentation of subarachnoid hemorrhage until proven otherwise. Non-contrast CT brain performed within 6 hours of symptom onset has very high sensitivity for detecting subarachnoid blood and is the first-line investigation. It is rapid, widely available, and avoids the invasiveness of lumbar puncture as an initial test. If the CT is negative but clinical suspicion remains high, lumbar puncture for xanthochromia is the appropriate next step.

• A. CT angiography is used to identify the source of bleeding (e.g., aneurysm) after subarachnoid hemorrhage is confirmed, not as the initial screening test.
• C. Lumbar puncture is reserved for cases where CT is negative but suspicion for subarachnoid hemorrhage remains high, not as the first test.
• D. MRI is less readily available in the acute setting and is not the first-line test for suspected subarachnoid hemorrhage.

This presentation fulfills the International Classification of Headache Disorders criteria for migraine without aura: recurrent attacks lasting 4-72 hours with at least two of unilateral location, pulsatile quality, moderate-to-severe intensity, or aggravation by activity, plus at least one of nausea/vomiting or photophobia/phonophobia. The normal neurological examination supports a primary headache disorder rather than a secondary cause. Tension-type headache is typically bilateral, pressing or band-like, and lacks significant nausea or marked photophobia. The episodic pattern over a year with these features is classic for migraine.

• A. Cluster headache causes severe unilateral periorbital pain with autonomic features such as lacrimation or nasal congestion, typically lasting 15-180 minutes, not hours.
• C. Tension-type headache is usually bilateral and pressing in quality, without significant nausea or photophobia.
• D. Trigeminal neuralgia causes brief, electric shock-like facial pain triggered by stimuli such as chewing or touch, not a throbbing headache lasting hours.

Triptans such as sumatriptan are first-line abortive therapy for moderate-to-severe migraine attacks that have not responded to simple analgesics. They act as selective serotonin 5-HT1B/1D receptor agonists, causing cranial vasoconstriction and inhibition of pro-inflammatory neuropeptide release at trigeminal nerve terminals. They are most effective when taken early in the attack and are contraindicated in patients with significant cardiovascular disease due to vasoconstrictive effects, which this patient does not have. Corticosteroids and preventive agents like amitriptyline have no role in aborting an acute attack.

• B. Corticosteroids are not first-line abortive therapy for migraine; they are sometimes used for refractory status migrainosus, not a typical acute attack.
• C. Intravenous mannitol is used to reduce intracranial pressure and has no role in migraine treatment.
• D. Amitriptyline is a preventive agent taken daily to reduce migraine frequency, not an abortive treatment for an acute attack.

Migraine prophylaxis is indicated when attacks are frequent (generally four or more days per month), prolonged, significantly impair quality of life, or are poorly responsive to abortive treatment. Beta-blockers such as propranolol are first-line prophylactic agents, supported by strong evidence for reducing migraine frequency and severity. Other first-line options include topiramate and certain antidepressants such as amitriptyline, chosen based on patient comorbidities and contraindications. Daily use of abortive medications like triptans or simple analgesics is discouraged because it risks medication-overuse headache.

• A. Increasing triptan dose addresses individual attacks, not the underlying frequency, and raises the risk of medication-overuse headache.
• B. With six attack days per month significantly affecting daily function, prophylaxis is clearly indicated, not withheld.
• D. Daily paracetamol use for prevention is inappropriate and predisposes to medication-overuse headache rather than reducing migraine frequency.

Triptans (serotonin 5-HT1B/1D receptor agonists) cause vasoconstriction of cranial and coronary vessels. In patients with established coronary artery disease, this can precipitate myocardial ischemia or infarction, so triptans are contraindicated in this group. Alternative acute therapies such as NSAIDs, antiemetics, or newer agents like gepants should be considered. Cardiovascular risk assessment is essential before prescribing a triptan to any migraine patient. This is a key safety point tested in licensing exams given the popularity of triptans for migraine.

• A. Triptans are not associated with significant liver toxicity.
• B. Triptans do not cause bone marrow suppression.
• C. Angle-closure glaucoma is not a recognized triptan risk; this is more associated with anticholinergics.

Tension-type headache is characterized by bilateral, pressing or tightening (non-pulsatile) pain of mild to moderate intensity that does not worsen with routine physical activity and lacks associated migrainous features such as nausea, photophobia, or phonophobia. Migraine, in contrast, is typically unilateral, pulsatile, aggravated by activity, and accompanied by nausea and/or photophobia or phonophobia. The absence of these migrainous features and the pressing bilateral quality strongly favor tension-type headache. Diagnosis is clinical, based on headache characteristics per the International Classification of Headache Disorders (ICHD-3).

• A. Cluster headache presents with severe unilateral periorbital pain with autonomic features, not bilateral band-like pain.
• C. Migraine typically has unilateral, pulsatile pain aggravated by activity and associated nausea or photophobia, which this patient lacks.
• D. There is no history of regular analgesic overuse described in this vignette.

This presentation is classic for cluster headache: severe unilateral periorbital pain with ipsilateral autonomic features (ptosis, conjunctival injection, rhinorrhea) occurring in bouts. First-line acute treatment is high-flow oxygen (100% at 12-15 L/min via non-rebreather mask for 15-20 minutes), which aborts most attacks within minutes. Subcutaneous or intranasal (not oral) triptans are the alternative acute option when oxygen is unavailable or ineffective, but oral triptans act too slowly for this short-lived attack. Oxygen has no significant systemic side effects and can be used repeatedly.

• B. Intravenous valproate is not a first-line acute treatment for cluster headache.
• C. Oral prednisolone may be used as a short-term preventive bridge therapy, not for acute attack termination.
• D. Oral triptans have too slow an onset for cluster attacks; subcutaneous or intranasal triptans are preferred when oxygen fails.

A thunderclap headache (reaching maximum intensity within seconds to a minute) is a red flag requiring urgent evaluation for subarachnoid hemorrhage. Non-contrast CT of the head is the first-line investigation and has very high sensitivity for subarachnoid hemorrhage when performed within 6 hours of symptom onset. If the CT is negative but suspicion remains, a lumbar puncture should follow to look for xanthochromia. Other red flags warranting imaging include new headache onset after age 50, neurological deficits, altered consciousness, and headache with fever or neck stiffness suggesting meningitis.

• B. Lumbar puncture should follow a normal CT, not precede it, due to risk of herniation if there is raised intracranial pressure.
• C. Discharge without imaging is unsafe given the high-risk thunderclap presentation.
• D. Treating empirically as migraine is inappropriate given the thunderclap onset, which mandates exclusion of subarachnoid hemorrhage first.

In a patient presenting with a first unprovoked seizure who has returned to baseline with a normal examination, electroencephalography is the key first-line investigation because it helps determine seizure type, identify an underlying epileptiform focus, and estimate the risk of recurrence, which guides decisions about starting antiepileptic therapy. Neuroimaging, preferably MRI brain, is also typically performed to exclude a structural cause, but EEG is the specific test that characterizes seizure activity and informs epilepsy risk. Routine lumbar puncture is not indicated in the absence of fever, meningism, or immunocompromise. Cardiac monitoring is reserved for cases where a convulsive syncope or arrhythmia is suspected rather than a true epileptic seizure.

• A. Holter monitoring is used when convulsive syncope from an arrhythmia is suspected, not for a classic generalized tonic-clonic seizure with postictal confusion.
• B. Carotid Doppler is not relevant to seizure evaluation; it is used in stroke or transient ischemic attack workup.
• C. Lumbar puncture is not indicated here in the absence of fever, meningism, or signs suggesting central nervous system infection.

This patient has convulsive status epilepticus, defined as a continuous seizure lasting more than 5 minutes or recurrent seizures without recovery of consciousness. Intravenous lorazepam is the first-line benzodiazepine because it has a rapid onset and a longer anticonvulsant duration of action in the central nervous system compared with diazepam, reducing the risk of early seizure recurrence. If intravenous access were not available, intramuscular midazolam or rectal diazepam would be reasonable alternatives. Benzodiazepines act by enhancing GABA-A receptor-mediated chloride influx, increasing neuronal inhibition.

• B. Mannitol is used to reduce raised intracranial pressure, not to treat active seizures.
• C. Morphine has no anticonvulsant effect and does not terminate status epilepticus.
• D. Phenytoin is a second-line agent given intravenously after benzodiazepine failure, not an oral first-line drug, and oral dosing is far too slow for an ongoing seizure.

Status epilepticus that persists despite two adequate doses of a benzodiazepine is termed benzodiazepine-refractory (established) status epilepticus, and guidelines recommend proceeding to an intravenous second-line antiepileptic rather than repeating benzodiazepines. Intravenous levetiracetam, fosphenytoin/phenytoin, or valproate are all acceptable second-line choices; levetiracetam is widely favored for its favorable safety profile, lack of significant drug interactions, and ease of administration. Repeated benzodiazepine dosing increases the risk of respiratory depression and hypotension without improving seizure control once two doses have failed. Early escalation reduces the risk of progression to refractory status epilepticus requiring anesthetic agents.

• A. A third benzodiazepine dose adds respiratory depression risk without added benefit once two doses have failed to terminate the seizure.
• B. Oral carbamazepine has slow absorption and is not used for acute status epilepticus management.
• C. Rectal diazepam is a benzodiazepine route used mainly in the prehospital or pediatric setting, not an appropriate second-line escalation here.

Psychogenic non-epileptic seizures are characterized by prolonged duration (often longer than typical epileptic seizures), closed eyes during the event, asynchronous or waxing-and-waning limb movements, pelvic thrusting, retained responsiveness to noxious stimuli, and rapid return to baseline without a postictal confusional state. A normal postictal prolactin further supports a non-epileptic event, since true generalized convulsive seizures typically cause a transient rise in serum prolactin. Video-electroencephalography capturing a typical event remains the diagnostic gold standard. Recognizing these features avoids unnecessary long-term antiepileptic therapy.

• A. Complex partial seizures involve impaired awareness with stereotyped automatisms, not prolonged waxing-and-waning bilateral limb shaking with eyes closed.
• B. Absence seizures are brief staring spells lasting seconds without convulsive limb movements.
• D. A true generalized tonic-clonic seizure causes eye opening, synchronous rhythmic jerking, unresponsiveness throughout, and a postictal confused state with elevated prolactin.

After a first unprovoked seizure, standard licensing regulations (reflected in UAE traffic medical fitness standards as well as international practice) require the individual to stop driving and notify the relevant licensing authority, with a mandatory seizure-free period, commonly around 6 to 12 months depending on jurisdiction and driving category, before fitness to drive can be reassessed. This is especially strict for professional or commercial drivers, who are typically held to longer seizure-free intervals than private drivers because of the greater risk to public safety. Immediate or short-interval return to driving is unsafe given the risk of seizure recurrence, which is highest in the weeks following a first event. The physician has both an ethical and often a legal duty to advise the patient of this restriction and document the discussion.

• B. A normal workup does not eliminate the risk of seizure recurrence, so immediate return to driving is unsafe and against regulation.
• C. Starting medication the same day does not eliminate the mandated seizure-free observation period required before driving can resume.
• D. No licensing authority permits return to driving after only 24 hours following a seizure.

A simple febrile seizure is defined as a generalized seizure lasting less than 15 minutes, occurring once in a 24-hour period, with full neurological recovery and no focal features, typically in a child aged 6 months to 5 years during a febrile illness without central nervous system infection. This child's seizure meets all these criteria, so management consists of reassurance, antipyretic and supportive care for the fever, and parental education, without the need for routine electroencephalography, neuroimaging, or lumbar puncture unless there are additional red flags such as meningeal signs or incomplete immunization status. Complex febrile seizures, in contrast, involve focal features, duration longer than 15 minutes, or recurrence within 24 hours, and warrant further neurological evaluation. Long-term antiepileptic prophylaxis is not recommended for simple febrile seizures because the overall risk of developing epilepsy is low and the medications carry their own risks.

• A. This episode lacks the focal features, prolonged duration, or recurrence within 24 hours that define a complex febrile seizure, so it does not meet criteria and imaging is not indicated.
• B. Lumbar puncture is reserved for cases with meningeal signs, incomplete immunization, or other red flags, not mandated for every febrile seizure.
• D. Daily antiepileptic prophylaxis is not recommended for simple febrile seizures given their benign course and low risk of future epilepsy.

Phenytoin causes gingival hyperplasia through stimulation of fibroblast proliferation and collagen synthesis in gum tissue, and nystagmus is an early sign of phenytoin toxicity related to cerebellar-vestibular effects. Other chronic effects include hirsutism, coarsening of facial features, osteomalacia, and peripheral neuropathy. Monitoring drug levels and dental hygiene can reduce the severity of gum overgrowth. Nystagmus at therapeutic doses may indicate the upper end of the therapeutic range, while ataxia and diplopia suggest frank toxicity.

• A. Levetiracetam is associated with behavioral/mood changes, not gum overgrowth or nystagmus.
• B. Lamotrigine is associated with skin rash including Stevens-Johnson syndrome, not gingival hyperplasia.
• D. Valproate is associated with weight gain, tremor, hepatotoxicity, and pancreatitis, not gingival hyperplasia.

Empirical therapy for community-acquired bacterial meningitis in adults should cover Streptococcus pneumoniae, Neisseria meningitidis, and the possibility of penicillin/cephalosporin-resistant pneumococcus, which is achieved with vancomycin plus a third-generation cephalosporin such as ceftriaxone. Ampicillin is added in patients over 50 years or immunocompromised to cover Listeria monocytogenes. Treatment should never be delayed for imaging or lumbar puncture results. This combination provides broad empirical coverage until CSF Gram stain and culture results are available.

• B. Doxycycline alone is inadequate and used for rickettsial or tick-borne infections, not bacterial meningitis.
• C. Ampicillin alone does not adequately cover resistant pneumococcus or meningococcus.
• D. Ciprofloxacin plus metronidazole targets Gram-negative and anaerobic organisms, not the typical meningitis pathogens.

Focal neurological deficits, altered consciousness, papilledema, or signs suggesting a mass lesion are indications for CT imaging before lumbar puncture to exclude a space-occupying lesion or significant midline shift that would increase the risk of cerebral herniation. Blood cultures and empirical antibiotics should be given immediately while awaiting imaging, and lumbar puncture performed afterward if the scan is safe. MRI is not the first-line or practical emergency imaging modality in this acute setting. Lumbar puncture should never be performed first when red-flag features for raised intracranial pressure are present.

• A. Antibiotics must not be delayed; they should be started empirically before or alongside the LP work-up, not withheld.
• B. MRI is not the practical first-line emergency choice; CT is faster and sufficient to assess for contraindications to LP.
• C. Performing lumbar puncture without prior imaging risks brain herniation in a patient with focal deficits and anisocoria.

Acute bacterial meningitis classically produces a markedly elevated opening pressure, a neutrophil-predominant pleocytosis often exceeding 1000 cells/microL, high protein, and a low CSF-to-serum glucose ratio below 0.4 due to bacterial glucose consumption. Viral meningitis typically shows a lymphocytic pleocytosis with normal or mildly elevated protein and normal glucose. Tuberculous meningitis usually shows a lymphocytic predominance with very high protein and a more gradual onset over days to weeks. The combination of marked neutrophilia, very low glucose, and high protein in this case is characteristic of a bacterial process.

• A. Tuberculous meningitis usually shows lymphocytic predominance and a more subacute presentation, not acute neutrophilic pleocytosis.
• C. Viral meningitis typically shows lymphocytic predominance with normal glucose, unlike the neutrophilic, hypoglycorrhachic picture here.
• D. These values are grossly abnormal and clearly inconsistent with a normal CSF profile.

Close contacts of a confirmed meningococcal meningitis case, including household members, roommates, and intimate contacts within the 7 days before symptom onset, require chemoprophylaxis to eradicate nasopharyngeal carriage and prevent secondary cases. Options include a single dose of oral ciprofloxacin, rifampicin for 2 days, or a single intramuscular dose of ceftriaxone. Prophylaxis should be given as soon as possible, ideally within 24 hours of diagnosis of the index case, and is most effective when given promptly. Vaccination may be offered additionally depending on the serogroup but does not replace antibiotic prophylaxis for immediate protection.

• A. Vaccination alone does not provide the immediate protection needed and does not replace antibiotic chemoprophylaxis for close contacts.
• C. A full 7-day course of IV ceftriaxone is unnecessary for an asymptomatic contact; a single dose of ceftriaxone or short oral prophylaxis suffices.
• D. Waiting for symptoms defeats the purpose of prophylaxis, since secondary cases can develop rapidly and prophylaxis aims to prevent them.

Herpes simplex encephalitis classically presents with fever, altered mental status, personality or language changes, and seizures, with MRI showing asymmetric temporal and frontal lobe involvement. Because HSE carries high mortality if untreated and early treatment improves outcomes, intravenous acyclovir should be started empirically as soon as the diagnosis is suspected, without waiting for PCR confirmation. Treatment is typically continued for 14 to 21 days, with CSF HSV PCR used to confirm the diagnosis. Oral antivirals do not achieve adequate CNS concentrations for treatment of encephalitis.

• A. Ganciclovir is used for cytomegalovirus infections, not herpes simplex encephalitis.
• B. Oral valacyclovir does not achieve sufficient CNS drug levels for treating encephalitis and is not the standard route.
• C. Ceftriaxone targets bacterial meningitis, not viral encephalitis, and would not address the underlying HSV infection.

Adjunctive dexamethasone in bacterial meningitis, particularly when Streptococcus pneumoniae is suspected or confirmed, has been shown to reduce mortality and neurological complications such as hearing loss, but only when given shortly before or concurrently with the first dose of antibiotics. Giving it after antibiotics have already been administered loses most of its benefit because it works by dampening the inflammatory response to bacterial lysis caused by antibiotics. Delayed administration beyond this window is not recommended as a routine strategy. Dexamethasone is generally continued for 4 days if started appropriately.

• A. Waiting 48 hours to assess response negates the benefit of dexamethasone, which depends on early co-administration with antibiotics.
• B. Dexamethasone should be given based on the diagnosis of bacterial meningitis itself, not reserved only for established raised intracranial pressure.
• D. Giving dexamethasone several hours after antibiotics have already triggered bacterial lysis and inflammation loses most of the therapeutic benefit.

The clinical diagnosis of Parkinson's disease requires bradykinesia as the core feature, in combination with either rest tremor, rigidity, or both, according to current diagnostic criteria such as the UK Brain Bank and MDS criteria. Rest tremor classically has a frequency of 4 to 6 Hz and diminishes with voluntary action, while rigidity has a characteristic cogwheel quality. Postural instability typically appears later in the disease course and is not required for the initial diagnosis. Early dementia and incontinence are atypical features that should raise suspicion for an alternative parkinsonian syndrome rather than idiopathic Parkinson's disease.

• B. Postural instability alone with tremor, without bradykinesia, is insufficient and postural instability is a late finding, not an early diagnostic requirement.
• C. Cerebellar ataxia is not a feature of Parkinson's disease and would suggest a different diagnosis such as multiple system atrophy.
• D. Early dementia and urinary incontinence alongside rigidity suggest an atypical parkinsonian syndrome rather than classic idiopathic Parkinson's disease.

In younger patients with early Parkinson's disease, a dopamine agonist such as pramipexole is preferred as initial therapy because it provides adequate symptom control while delaying the onset of levodopa-induced motor complications (fluctuations and dyskinesia), which are more likely to develop with earlier and longer exposure to levodopa in younger patients. Levodopa is more effective for motor symptoms but is generally reserved for older patients or when symptoms significantly impair function, given the cumulative risk of dyskinesia with cumulative levodopa exposure. Anticholinergics are limited by cognitive and autonomic side effects and are not first-line. Entacapone is a COMT inhibitor used as adjunct therapy to levodopa, not as monotherapy.

• A. Entacapone is a COMT inhibitor used only as an adjunct to levodopa, not as monotherapy.
• B. Anticholinergics have significant cognitive and autonomic side effects and are not first-line, especially in this age group.
• D. Effective but associated with earlier motor fluctuations and dyskinesia when started early in younger patients.

Long-term levodopa therapy is associated with motor fluctuations, including 'wearing-off' (return of parkinsonian symptoms before the next dose as plasma levodopa levels decline) and peak-dose dyskinesia (involuntary choreiform or dystonic movements occurring when striatal dopamine levels are highest). These complications result from pulsatile stimulation of denervated striatal dopamine receptors and non-physiological, intermittent dopaminergic signaling. Management options include fractionating doses, adding a COMT inhibitor or MAO-B inhibitor, or using extended-release formulations. This is distinct from the other listed conditions, which have different triggers and clinical pictures.

• A. Serotonin syndrome presents with hyperthermia, clonus, and autonomic instability, typically from serotonergic drug combinations, not levodopa dosing timing.
• B. Progressive supranuclear palsy is a distinct neurodegenerative disorder with early falls and vertical gaze palsy, not a levodopa complication.
• D. Neuroleptic malignant syndrome occurs with dopamine antagonist use or abrupt dopaminergic withdrawal, presenting with rigidity and hyperthermia, not dose-related dyskinesia.

Metoclopramide is a dopamine D2 receptor antagonist that crosses the blood-brain barrier and blocks striatal dopamine receptors, producing drug-induced parkinsonism that is typically bilateral and symmetric, unlike the asymmetric onset seen in idiopathic Parkinson's disease. Other D2-blocking drugs that commonly cause this include first-generation antipsychotics and some second-generation antipsychotics. Ondansetron is a 5-HT3 antagonist without significant central dopaminergic blockade. Omeprazole and loperamide do not act on central dopamine pathways and are not associated with parkinsonism.

• A. Ondansetron acts on serotonin 5-HT3 receptors and does not block central dopamine receptors.
• C. Loperamide acts on peripheral opioid receptors in the gut and does not cross the blood-brain barrier significantly.
• D. Omeprazole is a proton pump inhibitor with no dopaminergic activity.

Essential tremor classically presents as a bilateral postural and kinetic tremor (worse with sustained posture or action such as holding a cup) that characteristically improves with small amounts of alcohol and often has a positive family history, consistent with autosomal dominant inheritance in many cases. In contrast, Parkinsonian tremor is typically a unilateral resting tremor that decreases or disappears with voluntary action and is accompanied by bradykinesia and rigidity. The absence of rigidity, bradykinesia, and asymmetry in this patient favors essential tremor over Parkinson's disease.

• A. This re-emergent postural tremor pattern with asymmetric resting component is characteristic of Parkinson's disease, not essential tremor.
• C. This describes a pattern opposite to typical Parkinsonian resting tremor, which improves rather than worsens with voluntary movement.
• D. This patient has no rigidity or bradykinesia, which are core features of parkinsonian tremor, not essential tremor.

Huntington's disease is caused by an autosomal dominant CAG trinucleotide repeat expansion in the huntingtin (HTT) gene on chromosome 4, leading to progressive neurodegeneration of the striatum. It classically presents in mid-adulthood with chorea, behavioral and psychiatric changes, and progressive cognitive decline, often with a family history consistent with autosomal dominant inheritance and anticipation (earlier onset in successive generations). The other inheritance patterns listed are associated with different diseases (ataxia-telangiectasia, Duchenne muscular dystrophy, and mitochondrial disorders respectively) and do not produce this chorea-dementia phenotype.

• A. Duchenne muscular dystrophy is X-linked recessive and causes progressive muscle weakness, not chorea or dementia.
• C. Ataxia-telangiectasia is autosomal recessive and presents in childhood with ataxia and telangiectasia, not adult-onset chorea.
• D. Mitochondrial DNA mutations cause maternally inherited disorders with varied phenotypes, not the classic chorea-dementia syndrome described here.

Guillain-Barré syndrome typically follows an antecedent infection (commonly Campylobacter jejuni gastroenteritis) and presents with ascending, symmetric limb weakness with areflexia, consistent with an acute inflammatory demyelinating polyradiculoneuropathy. Cerebrospinal fluid analysis classically shows albuminocytologic dissociation: elevated protein with a normal white cell count, which supports the diagnosis, especially after the first week of symptoms. Nerve conduction studies showing demyelinating features are also valuable but CSF analysis is the key supportive investigation highlighted in guidelines alongside clinical criteria. Creatine kinase and spinal MRI are used to evaluate alternative diagnoses such as myopathy or structural cord compression, which are less consistent with this symmetric ascending areflexic pattern.

• B. Creatine kinase is used to evaluate myopathies, not demyelinating polyneuropathy, and is typically normal in Guillain-Barré syndrome.
• C. Nerve conduction studies are useful but CSF analysis for albuminocytologic dissociation is a key supportive test that should not be omitted in the diagnostic workup.
• D. Spinal MRI is used to exclude structural cord or cauda equina lesions, not to confirm Guillain-Barré syndrome.

In Guillain-Barré syndrome, respiratory failure results from progressive neuromuscular weakness of the diaphragm and intercostal muscles, and can occur before significant hypoxemia develops because oxygen saturation is often preserved until weakness is severe. Serial bedside spirometry measuring forced vital capacity (FVC) is the most appropriate tool to detect early respiratory muscle weakness; a decline in FVC below approximately 20 mL/kg, or a rapid downward trend, is an indication for intensive care admission and consideration of elective intubation before frank respiratory failure occurs. Arterial blood gas and pulse oximetry typically remain normal until weakness is advanced, making them insensitive for early detection. Chest X-ray does not assess respiratory muscle strength.

• B. Pulse oximetry is often falsely reassuring in neuromuscular respiratory failure because oxygen saturation remains normal until weakness is severe.
• C. Arterial blood gas abnormalities such as hypercapnia typically appear late, after significant respiratory muscle weakness has already developed.
• D. Chest X-ray evaluates lung parenchyma and does not assess neuromuscular respiratory function.

Intravenous immunoglobulin (IVIG), typically given at 0.4 g/kg/day for 5 days, is a first-line treatment for Guillain-Barré syndrome in patients unable to walk independently or with significant disability, and is equally effective as plasma exchange, with the two therapies considered interchangeable based on current guidelines. IVIG works by modulating the immune response and neutralizing pathogenic antibodies. Corticosteroids, whether oral or intravenous, have not been shown to improve outcomes in Guillain-Barré syndrome and are not recommended. Azathioprine is an immunosuppressant used in chronic autoimmune neuropathies, not in the acute management of GBS.

• A. Oral corticosteroids have not shown benefit in Guillain-Barré syndrome and are not part of standard treatment.
• B. Azathioprine is used for chronic immune-mediated neuropathies, not for acute Guillain-Barré syndrome.
• D. Intravenous corticosteroids also lack proven efficacy in Guillain-Barré syndrome and are not recommended by current guidelines.

The fatigable, fluctuating weakness affecting extraocular and proximal limb muscles is classic for myasthenia gravis, a postsynaptic neuromuscular junction disorder. Acetylcholine receptor (AChR) antibodies are present in about 85% of generalized cases and are the most specific first-line confirmatory test. Anti-MuSK antibodies are checked if AChR antibodies are negative. Edrophonium testing and repetitive nerve stimulation are alternatives but carry more risk or lower specificity and are not first-line in most centers today.

• A. Creatine kinase is elevated in myopathies, not in myasthenia gravis, where muscle enzymes are normal.
• B. Nerve conduction studies assess peripheral nerves and are normal in myasthenia gravis, a junctional disorder.
• D. Anti-Jo-1 antibodies are associated with polymyositis/dermatomyositis, not myasthenia gravis.

This patient has features of myasthenic crisis: respiratory distress, reduced forced vital capacity, and bulbar weakness, which is a medical emergency due to risk of respiratory failure. The priority is securing the airway and providing mechanical ventilation if vital capacity continues to fall or the patient tires, before pursuing disease-specific therapy such as plasmapheresis or intravenous immunoglobulin. Increasing cholinergic drugs can worsen secretions and risk cholinergic crisis and does not address impending respiratory failure. Diagnostic testing is not a priority when the airway is threatened.

• B. Corticosteroids take days to weeks to act and are not an emergency airway intervention.
• C. Increasing pyridostigmine does not address impending respiratory failure and risks cholinergic excess.
• D. Diagnostic electrophysiology is not appropriate when the patient has impending respiratory failure.

The history and positive Tinel's and Phalen's signs confirm carpal tunnel syndrome from median nerve compression at the wrist. In mild to moderate cases without thenar atrophy or significant denervation, night-time splinting in a neutral wrist position is the recommended first-line conservative treatment, as it reduces nerve compression during sleep when symptoms are worst. Corticosteroid injection and surgery are reserved for cases that fail conservative measures or show significant motor/sensory deficits. Gabapentin is not a standard first-line treatment for a mechanical entrapment neuropathy.

• A. Corticosteroid injection is a second-line option after a trial of splinting has failed.
• C. Surgery is reserved for refractory cases or those with thenar wasting, not as first-line therapy.
• D. Gabapentin is used for neuropathic pain generally but is not first-line for a compressive mononeuropathy that responds to splinting.

This presentation with acute unilateral lower motor neuron facial weakness involving the forehead, in the absence of other neurological signs, is typical of Bell's palsy, an idiopathic facial nerve palsy. Oral corticosteroids started within 72 hours of symptom onset significantly improve the chance of complete recovery and are the guideline-recommended first-line treatment. Forehead involvement distinguishes this lower motor neuron lesion from a central (upper motor neuron) cause, which spares the forehead. Antiviral monotherapy has not shown proven benefit and surgical decompression is not routinely recommended.

• A. Antivirals alone have not been shown to improve outcomes and are not first-line monotherapy.
• C. Surgical decompression is not a standard or first-line treatment for typical Bell's palsy.
• D. Delaying steroids beyond the early window reduces their effectiveness in improving recovery.

Saddle anesthesia, urinary retention, and reduced anal sphincter tone with bilateral leg weakness are red flag features of cauda equina syndrome, a surgical emergency caused by compression of the lumbosacral nerve roots. Urgent MRI of the lumbosacral spine is required without delay to confirm the diagnosis and guide emergency surgical decompression, since delay beyond 48 hours significantly worsens the chance of recovering bladder, bowel, and sexual function. Plain radiographs do not visualize soft tissue or nerve root compression adequately. Conservative outpatient management is inappropriate and dangerous in this emergency, and lumbar puncture is not indicated and could be harmful if there is a mass lesion.

• A. Outpatient conservative management risks permanent bladder, bowel, and sexual dysfunction in this surgical emergency.
• C. Plain radiographs cannot adequately visualize the soft tissue and neural structures required to diagnose cauda equina syndrome.
• D. Lumbar puncture does not diagnose cauda equina syndrome and may be hazardous with a compressive lesion.

Weakness of ankle plantar flexion, difficulty toe-walking, a diminished ankle reflex, and sensory loss over the lateral foot and little toe localize to the S1 nerve root, most commonly compressed by an L5-S1 disc herniation. In contrast, L5 radiculopathy causes weakness of ankle dorsiflexion and great toe extension with sensory loss over the dorsum of the foot and first web space, and the ankle reflex is preserved. Recognizing this motor, sensory, and reflex pattern allows clinical localization of the compressed nerve root without imaging.

• A. L5 radiculopathy causes dorsiflexion weakness and dorsal foot sensory loss, with a preserved ankle reflex.
• B. L3 radiculopathy causes anterior thigh and knee symptoms with a diminished knee reflex, not ankle findings.
• C. L4 radiculopathy causes weakness of knee extension and a diminished knee (patellar) reflex, not ankle plantar flexion weakness.

Progressive back pain, bilateral leg weakness, a sensory level, and sphincter disturbance in a patient with known metastatic cancer strongly suggest malignant spinal cord compression, an oncological emergency. Immediate high-dose intravenous dexamethasone reduces cord edema and can preserve neurological function, and urgent whole-spine MRI is required within 24 hours to confirm the level and extent of compression and plan emergency radiotherapy or surgical decompression. Delaying imaging or steroids risks irreversible paralysis. Lumbar puncture is not indicated and may be dangerous in the presence of a spinal mass.

• A. Radiotherapy planning over weeks is far too slow for an evolving cord compression emergency.
• B. Lumbar puncture does not diagnose cord compression and is potentially hazardous with a spinal mass lesion.
• C. Delaying imaging by a week risks irreversible spinal cord damage in this emergency.

This patient has signs of raised intracranial pressure with impending transtentorial herniation: a unilateral dilated, sluggishly reactive pupil (third nerve compression), Cushing's reflex (hypertension with bradycardia), and reduced consciousness. Intravenous mannitol is a first-line hyperosmolar agent that acutely reduces intracranial pressure by drawing fluid out of brain tissue, while urgent neurosurgical referral is needed for definitive decompression or tumor resection. Dexamethasone reduces vasogenic edema but acts over hours and is not sufficient alone in an evolving herniation emergency. Lumbar puncture is contraindicated with a mass lesion and risks precipitating herniation.

• B. Aggressive hyperventilation to very low PaCO2 risks cerebral ischemia and is used only briefly as a bridge, not as primary management.
• C. Lumbar puncture is contraindicated with a mass lesion and raised ICP due to the risk of fatal herniation.
• D. Dexamethasone reduces tumor-associated edema but has a slower onset and is inadequate as sole therapy in impending herniation.

The clinical picture, gradual memory loss, impaired instrumental activities of daily living, and disorientation in a previously independent older adult, is typical of Alzheimer's disease. The Mini-Mental State Examination (MMSE) is the most widely used first-line bedside tool to quantify the severity of cognitive impairment and track progression, scoring domains including orientation, memory, language, and praxis. The Glasgow Coma Scale assesses level of consciousness in acute settings, not chronic cognitive decline. The clock drawing test is a useful adjunct for visuospatial and executive function but is not a comprehensive standalone cognitive screen.

• A. The clock drawing test assesses visuospatial and executive function alone and is used as an adjunct, not a complete initial cognitive assessment.
• C. The Glasgow Coma Scale measures level of consciousness after acute brain injury, not chronic cognitive decline.
• D. The Beck Depression Inventory screens for depressive symptoms, not cognitive function, though depression should be excluded as a differential.

This patient's cognitive slowing accompanied by cold intolerance, weight gain, bradycardia, dry skin, and delayed reflex relaxation strongly suggests hypothyroidism, a classic and reversible cause of cognitive impairment. Measuring serum thyroid-stimulating hormone (TSH) is the standard screening test, and an elevated level with low free T4 confirms primary hypothyroidism, which improves with levothyroxine replacement. Reversible dementia workups routinely include TSH, vitamin B12, and calcium alongside structural imaging. Ceruloplasmin is used to evaluate for Wilson disease, which presents at a younger age with hepatic and movement disorders, not this picture.

• B. Oligoclonal bands support a diagnosis of multiple sclerosis, which does not fit this patient's clinical picture.
• C. Serum ammonia is used to evaluate hepatic encephalopathy, which this patient's history and examination do not suggest.
• D. Ceruloplasmin screens for Wilson disease, which typically presents in younger patients with liver disease and movement disorders.

The triad of gait disturbance, cognitive decline, and urinary incontinence, together with ventriculomegaly out of proportion to atrophy, is characteristic of normal pressure hydrocephalus (NPH). The large-volume lumbar puncture, or 'tap test,' involves removing 30–50 mL of cerebrospinal fluid and reassessing gait; objective improvement supports the diagnosis and predicts response to ventriculoperitoneal shunting. Gait is typically the most reversible feature and the first to improve after CSF removal. DAT scan is used to differentiate Parkinson's disease from other parkinsonian syndromes, not to diagnose NPH.

• B. A DAT scan helps distinguish Parkinson's disease from essential tremor or drug-induced parkinsonism, not to confirm NPH.
• C. Polysomnography diagnoses sleep disorders such as obstructive sleep apnea, unrelated to this presentation.
• D. These tests evaluate for Wilson disease, which does not match this patient's age and presentation.

Delirium is characterized by acute onset (hours to days) and a fluctuating course with impaired attention and altered level of consciousness, often triggered by an underlying acute illness such as this patient's urinary tract infection. Dementia, in contrast, develops gradually over months to years with a relatively stable level of consciousness and attention until late stages. While memory impairment, word-finding difficulty, and disorientation can occur in both conditions, they do not reliably distinguish the two. Recognizing delirium is essential because it signals an acute, often reversible, medical illness requiring urgent treatment.

• A. Word-finding difficulty can occur in both conditions and is not a distinguishing feature.
• B. Disorientation is common to both delirium and dementia and does not help differentiate them.
• D. Memory impairment occurs in both delirium and dementia and does not distinguish between them.

Recurrent episodes of neurological dysfunction separated in time and anatomical location, here optic neuritis followed by a prior sensory episode, are suggestive of multiple sclerosis. Contrast-enhanced MRI of the brain and spinal cord is the best confirmatory investigation, as it can demonstrate demyelinating lesions disseminated in space (periventricular, juxtacortical, spinal cord) and detect gadolinium-enhancing active lesions supporting dissemination in time, fulfilling the McDonald diagnostic criteria. Visual evoked potentials can support a diagnosis of prior optic neuritis but do not establish the full diagnostic criteria. CSF oligoclonal bands are supportive but secondary to MRI findings.

• A. CT angiography evaluates vascular pathology and is not relevant to diagnosing a demyelinating disease.
• C. Visual evoked potentials can confirm optic nerve demyelination but are not the primary confirmatory test for MS.
• D. Oligoclonal bands support the diagnosis when MRI is inconclusive but are not the first-line confirmatory investigation.

This patient's brief, severe, paroxysmal, electric shock-like facial pain triggered by light touch, with a normal neurological examination, is classic for trigeminal neuralgia. Carbamazepine is the first-line pharmacologic treatment, working by blocking voltage-gated sodium channels to reduce the ectopic, high-frequency neuronal firing responsible for the paroxysmal pain. Most patients experience significant relief within days of starting therapy. Amitriptyline and gabapentin are used for other neuropathic pain syndromes but are not first-line for trigeminal neuralgia, and conventional analgesics such as ibuprofen are ineffective for this neuropathic pain.

• A. NSAIDs such as ibuprofen are ineffective for the neuropathic pain of trigeminal neuralgia.
• B. Amitriptyline is useful for other neuropathic pain conditions but is not first-line for trigeminal neuralgia.
• C. Gabapentin may be used as an alternative or adjunct but is not the first-line agent for trigeminal neuralgia.